Tumor Targeting Peptides are short peptides that can specifically recognize and bind to specific receptors or antigens on the surface of tumor cells. These peptides can be used for diagnosis, treatment and imaging of tumors because they have high specificity and affinity, can effectively target tumor cells and reduce damage to normal cells.
The global Tumor Targeting Peptides market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Tumor Targeting Peptides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tumor Targeting Peptides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tumor Targeting Peptides include Cayman Chemical, Danaher(Abcam), Selleck Chemicals, Cell Guidance Systems, RayBiotech, Merck KGaA, PEPTIDE INSTITUTE, Bachem, ASIA BIOSCIENCE CO, Biorbyt, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tumor Targeting Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Targeting Peptides.
The Tumor Targeting Peptides market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Tumor Targeting Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Targeting Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Cayman Chemical
Danaher(Abcam)
Selleck Chemicals
Cell Guidance Systems
RayBiotech
Merck KGaA
PEPTIDE INSTITUTE
Bachem
ASIA BIOSCIENCE CO
Biorbyt
CPC Scientific Inc
Advanced ChemTech
TargetMol Chemicals
QYAOBIO
Segment by Type
Therapeutic Targeting Peptides
Imaging Targeting Peptides
Segment by Application
Scientific Research
Pharmaceuticals
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tumor Targeting Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tumor Targeting Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Tumor Targeting Peptides 麻豆原创 Overview
1.1 Product Definition
1.2 Tumor Targeting Peptides by Type
1.2.1 Global Tumor Targeting Peptides 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Therapeutic Targeting Peptides
1.2.3 Imaging Targeting Peptides
1.3 Tumor Targeting Peptides by Application
1.3.1 Global Tumor Targeting Peptides 麻豆原创 Value by Application (2024-2030)
1.3.2 Scientific Research
1.3.3 Pharmaceuticals
1.4 Global Tumor Targeting Peptides 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Tumor Targeting Peptides Revenue 2019-2030
1.4.2 Global Tumor Targeting Peptides Sales 2019-2030
1.4.3 Global Tumor Targeting Peptides 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tumor Targeting Peptides 麻豆原创 Competition by Manufacturers
2.1 Global Tumor Targeting Peptides Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Tumor Targeting Peptides Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Tumor Targeting Peptides Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Tumor Targeting Peptides, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tumor Targeting Peptides, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tumor Targeting Peptides, Product Type & Application
2.7 Global Key Manufacturers of Tumor Targeting Peptides, Date of Enter into This Industry
2.8 Global Tumor Targeting Peptides 麻豆原创 Competitive Situation and Trends
2.8.1 Global Tumor Targeting Peptides 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Tumor Targeting Peptides Players 麻豆原创 Share by Revenue
2.8.3 Global Tumor Targeting Peptides 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tumor Targeting Peptides 麻豆原创 Scenario by Region
3.1 Global Tumor Targeting Peptides 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tumor Targeting Peptides Sales by Region: 2019-2030
3.2.1 Global Tumor Targeting Peptides Sales by Region: 2019-2024
3.2.2 Global Tumor Targeting Peptides Sales by Region: 2025-2030
3.3 Global Tumor Targeting Peptides Revenue by Region: 2019-2030
3.3.1 Global Tumor Targeting Peptides Revenue by Region: 2019-2024
3.3.2 Global Tumor Targeting Peptides Revenue by Region: 2025-2030
3.4 North America Tumor Targeting Peptides 麻豆原创 Facts & Figures by Country
3.4.1 North America Tumor Targeting Peptides 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tumor Targeting Peptides Sales by Country (2019-2030)
3.4.3 North America Tumor Targeting Peptides Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tumor Targeting Peptides 麻豆原创 Facts & Figures by Country
3.5.1 Europe Tumor Targeting Peptides 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tumor Targeting Peptides Sales by Country (2019-2030)
3.5.3 Europe Tumor Targeting Peptides Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tumor Targeting Peptides 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Tumor Targeting Peptides 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tumor Targeting Peptides Sales by Region (2019-2030)
3.6.3 Asia Pacific Tumor Targeting Peptides Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tumor Targeting Peptides 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Tumor Targeting Peptides 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tumor Targeting Peptides Sales by Country (2019-2030)
3.7.3 Latin America Tumor Targeting Peptides Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tumor Targeting Peptides 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Tumor Targeting Peptides 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tumor Targeting Peptides Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tumor Targeting Peptides Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tumor Targeting Peptides Sales by Type (2019-2030)
4.1.1 Global Tumor Targeting Peptides Sales by Type (2019-2024)
4.1.2 Global Tumor Targeting Peptides Sales by Type (2025-2030)
4.1.3 Global Tumor Targeting Peptides Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Tumor Targeting Peptides Revenue by Type (2019-2030)
4.2.1 Global Tumor Targeting Peptides Revenue by Type (2019-2024)
4.2.2 Global Tumor Targeting Peptides Revenue by Type (2025-2030)
4.2.3 Global Tumor Targeting Peptides Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Tumor Targeting Peptides Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tumor Targeting Peptides Sales by Application (2019-2030)
5.1.1 Global Tumor Targeting Peptides Sales by Application (2019-2024)
5.1.2 Global Tumor Targeting Peptides Sales by Application (2025-2030)
5.1.3 Global Tumor Targeting Peptides Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Tumor Targeting Peptides Revenue by Application (2019-2030)
5.2.1 Global Tumor Targeting Peptides Revenue by Application (2019-2024)
5.2.2 Global Tumor Targeting Peptides Revenue by Application (2025-2030)
5.2.3 Global Tumor Targeting Peptides Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Tumor Targeting Peptides Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Cayman Chemical
6.1.1 Cayman Chemical Company Information
6.1.2 Cayman Chemical Description and Business Overview
6.1.3 Cayman Chemical Tumor Targeting Peptides Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Cayman Chemical Tumor Targeting Peptides Product Portfolio
6.1.5 Cayman Chemical Recent Developments/Updates
6.2 Danaher(Abcam)
6.2.1 Danaher(Abcam) Company Information
6.2.2 Danaher(Abcam) Description and Business Overview
6.2.3 Danaher(Abcam) Tumor Targeting Peptides Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Danaher(Abcam) Tumor Targeting Peptides Product Portfolio
6.2.5 Danaher(Abcam) Recent Developments/Updates
6.3 Selleck Chemicals
6.3.1 Selleck Chemicals Company Information
6.3.2 Selleck Chemicals Description and Business Overview
6.3.3 Selleck Chemicals Tumor Targeting Peptides Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Selleck Chemicals Tumor Targeting Peptides Product Portfolio
6.3.5 Selleck Chemicals Recent Developments/Updates
6.4 Cell Guidance Systems
6.4.1 Cell Guidance Systems Company Information
6.4.2 Cell Guidance Systems Description and Business Overview
6.4.3 Cell Guidance Systems Tumor Targeting Peptides Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cell Guidance Systems Tumor Targeting Peptides Product Portfolio
6.4.5 Cell Guidance Systems Recent Developments/Updates
6.5 RayBiotech
6.5.1 RayBiotech Company Information
6.5.2 RayBiotech Description and Business Overview
6.5.3 RayBiotech Tumor Targeting Peptides Sales, Revenue and Gross Margin (2019-2024)
6.5.4 RayBiotech Tumor Targeting Peptides Product Portfolio
6.5.5 RayBiotech Recent Developments/Updates
6.6 Merck KGaA
6.6.1 Merck KGaA Company Information
6.6.2 Merck KGaA Description and Business Overview
6.6.3 Merck KGaA Tumor Targeting Peptides Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merck KGaA Tumor Targeting Peptides Product Portfolio
6.6.5 Merck KGaA Recent Developments/Updates
6.7 PEPTIDE INSTITUTE
6.7.1 PEPTIDE INSTITUTE Company Information
6.7.2 PEPTIDE INSTITUTE Description and Business Overview
6.7.3 PEPTIDE INSTITUTE Tumor Targeting Peptides Sales, Revenue and Gross Margin (2019-2024)
6.7.4 PEPTIDE INSTITUTE Tumor Targeting Peptides Product Portfolio
6.7.5 PEPTIDE INSTITUTE Recent Developments/Updates
6.8 Bachem
6.8.1 Bachem Company Information
6.8.2 Bachem Description and Business Overview
6.8.3 Bachem Tumor Targeting Peptides Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bachem Tumor Targeting Peptides Product Portfolio
6.8.5 Bachem Recent Developments/Updates
6.9 ASIA BIOSCIENCE CO
6.9.1 ASIA BIOSCIENCE CO Company Information
6.9.2 ASIA BIOSCIENCE CO Description and Business Overview
6.9.3 ASIA BIOSCIENCE CO Tumor Targeting Peptides Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ASIA BIOSCIENCE CO Tumor Targeting Peptides Product Portfolio
6.9.5 ASIA BIOSCIENCE CO Recent Developments/Updates
6.10 Biorbyt
6.10.1 Biorbyt Company Information
6.10.2 Biorbyt Description and Business Overview
6.10.3 Biorbyt Tumor Targeting Peptides Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Biorbyt Tumor Targeting Peptides Product Portfolio
6.10.5 Biorbyt Recent Developments/Updates
6.11 CPC Scientific Inc
6.11.1 CPC Scientific Inc Company Information
6.11.2 CPC Scientific Inc Description and Business Overview
6.11.3 CPC Scientific Inc Tumor Targeting Peptides Sales, Revenue and Gross Margin (2019-2024)
6.11.4 CPC Scientific Inc Tumor Targeting Peptides Product Portfolio
6.11.5 CPC Scientific Inc Recent Developments/Updates
6.12 Advanced ChemTech
6.12.1 Advanced ChemTech Company Information
6.12.2 Advanced ChemTech Description and Business Overview
6.12.3 Advanced ChemTech Tumor Targeting Peptides Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Advanced ChemTech Tumor Targeting Peptides Product Portfolio
6.12.5 Advanced ChemTech Recent Developments/Updates
6.13 TargetMol Chemicals
6.13.1 TargetMol Chemicals Company Information
6.13.2 TargetMol Chemicals Description and Business Overview
6.13.3 TargetMol Chemicals Tumor Targeting Peptides Sales, Revenue and Gross Margin (2019-2024)
6.13.4 TargetMol Chemicals Tumor Targeting Peptides Product Portfolio
6.13.5 TargetMol Chemicals Recent Developments/Updates
6.14 QYAOBIO
6.14.1 QYAOBIO Company Information
6.14.2 QYAOBIO Description and Business Overview
6.14.3 QYAOBIO Tumor Targeting Peptides Sales, Revenue and Gross Margin (2019-2024)
6.14.4 QYAOBIO Tumor Targeting Peptides Product Portfolio
6.14.5 QYAOBIO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tumor Targeting Peptides Industry Chain Analysis
7.2 Tumor Targeting Peptides Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tumor Targeting Peptides Production Mode & Process
7.4 Tumor Targeting Peptides Sales and 麻豆原创ing
7.4.1 Tumor Targeting Peptides Sales Channels
7.4.2 Tumor Targeting Peptides Distributors
7.5 Tumor Targeting Peptides Customers
8 Tumor Targeting Peptides 麻豆原创 Dynamics
8.1 Tumor Targeting Peptides Industry Trends
8.2 Tumor Targeting Peptides 麻豆原创 Drivers
8.3 Tumor Targeting Peptides 麻豆原创 Challenges
8.4 Tumor Targeting Peptides 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Cayman Chemical
Danaher(Abcam)
Selleck Chemicals
Cell Guidance Systems
RayBiotech
Merck KGaA
PEPTIDE INSTITUTE
Bachem
ASIA BIOSCIENCE CO
Biorbyt
CPC Scientific Inc
Advanced ChemTech
TargetMol Chemicals
QYAOBIO
听
听
*If Applicable.